510(k) · Cleared
ClearedVisby Medical Sexual Health
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Visby Medical · QEP Nucleic Acid Detection System For Non-Viral Microorganism (S) Causing Sexually Transmitted Infections
Cleared on Aug 26, 2021 as substantially equivalent to K121710 (Cepheid, 2012) and 1 other predicate after a 521-day review. Its family tree reaches back 4 generations to 1996. 2 later devices descend from it.
- Decided
- Aug 26, 2021
- Review
- 521 days
- Class
- Class II
- Product code
- QEP
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 4 generations to P950039 (1996). 9 ancestors in all. 2 later devices descend from it, 1 citing it directly.
- Root · 4 generations backP950039 Thinprep (R) Processor, Model TP 2000Hologic, Inc. · 1996
- 3 generations backK043224 Gen-Probe Aptima Combo 2 AssayGen-Probe, Inc. · 2005
- 2 generations backK121710 Xpert CT/NGCepheid · 2012 · Recalled
- 1 generation backK151565 Xpert® TV Assay on the Cepheid GeneXpert Instrument Systems…Cepheid · 2015
- This deviceK200748 Visby Medical Sexual HealthVisby Medical · 2021
- Descendant · cites it directly · 1 of its ownK220407 Visby Medical Sexual Health TestVisby Medical · 2023
- Descendant · 2 generations on · 0 of its ownK251501 Visby Medical Men's Sexual Health TestVisby Medical, Inc. · 2025
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | P950039 | Thinprep (R) Processor, Model TP 2000 | Hologic, Inc. | 1996 | — |
| −3 | K043224 | Gen-Probe Aptima Combo 2 Assay | Gen-Probe, Inc. | 2005 | — |
| −2 | K121710 | Xpert CT/NG | Cepheid | 2012 | 3 |
| −1 | K151565 | Xpert® TV Assay on the Cepheid GeneXpert Instrument Systems (GeneXpert Dx… | Cepheid | 2015 | — |
| 0 (this device) | K200748 | Visby Medical Sexual Health | Visby Medical | 2021 | — |
| +1 | K220407 | Visby Medical Sexual Health Test | Visby Medical | 2023 | — |
| +2 | K251501 | Visby Medical Men's Sexual Health Test | Visby Medical, Inc. | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2001 | 2 | 0 |
| 2005 | 1 | 0 |
| 2011 | 1 | 0 |
| 2013 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2023 | 1 | 0 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QEP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new QEP device
- #1 K260917 cobas CT/NG for use on the cobas…score 13.7 · 8 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K121710 | Xpert CT/NGSummary page 4…evices The Visby Medical Sexual Health Click Test is substantially equivalent to the Cepheid Xpert® CT/NG Assay and Cepheid Xpert® TV Assay, cleared under K121710 and K151565 on December 27, 2012 and October 16, 2015, respectively. D. Intended Use The Visby Medical Sexual… | 2012 |
| * | K151565 | Xpert® TV Assay on the Cepheid GeneXpert Instrument Systems (GeneXpert Dx, GeneXpert…Summary page 4…Visby Medical Sexual Health Click Test is substantially equivalent to the Cepheid Xpert® CT/NG Assay and Cepheid Xpert® TV Assay, cleared under K121710 and K151565 on December 27, 2012 and October 16, 2015, respectively. D. Intended Use The Visby Medical Sexual Health Click Test… | 2015 |
What descends from it? (2)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K220407 | Visby Medical Sexual Health Test | 2023 | 1 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 25 years and passes through 4 companies; a new generation was cleared every 7.4 years on median.
- 2 of the 9 ancestors have a recall of any class.
- Of its descendants, K220407 (Visby Medical, 2023) has gone furthest, with 1 descendant of its own.
- 2 other devices also cite its predicate K121710.
How does its category compare?
All QEP devicesQEP Nucleic Acid Detection System For Non-Viral Microorganism (S) Causing Sexually Transmitted Infections: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.
FDA decisions per year · QEP
4in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · QEP
268in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · QEP
3in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · QEP
9in 2025
MAUDE reports naming product code QEP, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 5 | 85 | 0 | 0 |
| 2020 | 3 | 46 | 0 | 0 |
| 2021 | 3 | 521 | 0 | 1 |
| 2022 | 3 | 438 | 0 | 1 |
| 2023 | 3 | 325 | 0 | 8 |
| 2024 | 0 | — | 3 | 8 |
| 2025 | 4 | 268 | 0 | 9 |
| 2026 | 3 | 171 | 0 | — |
What is it indicated for?
The Visby Medical Sexual Health Click Test is a single-use (disposable), fully-integrated, automated Polymerase Chain Reaction (PCR) in vitro diagnostic test intended for use in point-of-care or clinical laboratory settings for the rapid detection and differentiation of DNA from Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in self-collected female vaginal swab specimens using the Visby Medical Sexual Health Vaginal Specimen Collection Kit in a health care setting. The test results are to aid in the diagnosis of symptomatic or asymptomatic infections with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K200748 · printed Nov 3, 2026
Cite this page
510(k) Report. “K200748: Visby Medical Sexual Health.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K200748
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026